scholarly journals Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial

2020 ◽  
Vol 21 ◽  
pp. 77-84 ◽  
Author(s):  
Julia Murray ◽  
Sarah Gulliford ◽  
Clare Griffin ◽  
Anna Wilkins ◽  
Isabel Syndikus ◽  
...  
2017 ◽  
Vol 19 (1) ◽  
pp. 174-183 ◽  
Author(s):  
Jarryd G. Buckley ◽  
Dean Wilkinson ◽  
Alessandra Malaroda ◽  
Peter Metcalfe

Author(s):  
Carl Rowbottom

Chapter 3 discusses how successful delivery of external beam radiotherapy involves a number of complex processes beginning with the decision by the clinical oncologist to use radiotherapy as part of the patient’s cancer management, through the preparation and planning of the patient’s treatment, to the verification of the patient position and radiation dose delivered at the time of treatment.


2017 ◽  
Vol 29 (3) ◽  
pp. e86 ◽  
Author(s):  
J. Murray ◽  
J. Dean ◽  
H. Mossop ◽  
E. Hall ◽  
D. Dearnaley ◽  
...  

2019 ◽  
pp. 27-52
Author(s):  
Yat Man Tsang

Chapter 3 discusses how successful delivery of external beam radiotherapy such as intensity-modulated radiotherapy and image-guided radiotherapy involves a number of complex processes beginning with the decision by the clinical oncologist to use radiotherapy as part of the patient’s cancer management, through the preparation and planning of the patient’s treatment, to the verification of the patient position and radiation dose delivered at the time of treatment.


2012 ◽  
Vol 98 (6) ◽  
pp. 709-714 ◽  
Author(s):  
Nam P Nguyen ◽  
Misty Ceizyk ◽  
Vincent Vinh-Hung ◽  
Thomas Sroka ◽  
Siyoung Jang ◽  
...  

Aims and background To evaluate the effectiveness of tomotherapy-based image-guided radiotherapy (IGRT) on the radiation dose to the cochlea in patients with nasopharyngeal cancer. Methods and study design A retrospective review of five patients undergoing concurrent chemoradiation with tomotherapy for locally advanced nasopharyngeal cancer was performed. Results The mean dose to the right and left cochlea was 25 Gy and 35.3 Gy respectively, while the dose to the gross tumor ranged from 70 to 75 Gy. All patients had excellent clinical response to the treatment at a median follow-up of five months. Conclusions IGRT for head and neck cancer delivered by tomotherapy can significantly decrease the radiation dose to the cochlea without sacrificing target volume coverage.


2004 ◽  
Vol 31 (5) ◽  
pp. 1083-1092 ◽  
Author(s):  
William C. Lavely ◽  
Christopher Scarfone ◽  
Hakan Cevikalp ◽  
Rui Li ◽  
Daniel W. Byrne ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document